Education
About Us
Working with TipRanks
Follow Us
Palisade Bio (PALI)
NASDAQ:PALI
See the Price Targets and Ratings of:
PALI Financial Forecast
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Maxim Group
$8
Buy
1026.76%
Upside
Reiterated
12/03/24
Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (NYSE: EW), Evolent Health (NYSE: EVH) and Palisade Bio (NASDAQ: PALI)
Brookline Capital Markets
$38
Buy
5252.11%
Upside
Initiated
11/20/24
Palisade Bio initiated with a Buy at BrooklinePalisade Bio initiated with a Buy at Brookline
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Maxim Group
$8
Buy
1026.76%
Upside
Reiterated
12/03/24
Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (NYSE: EW), Evolent Health (NYSE: EVH) and Palisade Bio (NASDAQ: PALI)
Brookline Capital Markets
$38
Buy
5252.11%
Upside
Initiated
11/20/24
Palisade Bio initiated with a Buy at BrooklinePalisade Bio initiated with a Buy at Brookline
Best Analysts Covering Palisade Bio
Which Analyst Should I Follow If I Want to Buy PALI and Sell After:
1 Month
xxx
Success Rate
3/15 ratings generated profit
Average Return
-12.65%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 20.00% of your transactions generating a profit, with an average return of -12.65% per trade.
3 Months
xxx
Success Rate
0/15 ratings generated profit
Average Return
-42.65%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -42.65% per trade.
1 Year
Success Rate
0/15 ratings generated profit
Average Return
-79.85%
reiterated a buy rating 4 months ago
Copying Naz Rahman's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -79.85% per trade.
2 Years
xxx
Success Rate
0/15 ratings generated profit
Average Return
-81.69%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -81.69% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
PALI Analyst Recommendation Trends
Rating
Aug 24
Sep 24
Oct 24
Nov 24
Dec 24
Strong Buy
4
4
3
4
4
Buy
0
0
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
4
4
3
4
4
Each month's total comprises the sum of three months' worth of ratings.
PALI Stock Forecast FAQ
What is PALI’s average 12-month price target, according to analysts?
Based on analyst ratings, Palisade Bio’s 12-month average price target is $8.00.
What is PALI’s upside potential, based on the analysts’ average price target?
Palisade Bio has 1026.76% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is PALI a Buy, Sell or Hold?
Palisade Bio has a consensus rating of Moderate Buy which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
What is Palisade Bio’s price target?
The average price target for Palisade Bio is $8.00. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $8.00 ,the lowest forecast is $8.00. The average price target represents 1026.76% Increase from the current price of $0.71.
The highest analyst price target is $8.00 ,the lowest forecast is $8.00. The average price target represents 1026.76% Increase from the current price of $0.71.
What do analysts say about Palisade Bio?
Palisade Bio’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 0 Wall Streets Analysts.
How can I buy shares of PALI?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.